Fatal infantile mitochondrial myopathy and renal dysfunction due to cytochrome-c-oxidase deficiency. 1980

S DiMauro, and J R Mendell, and Z Sahenk, and D Bachman, and A Scarpa, and R M Scofield, and C Reiner

A 1-month-old boy was admitted because of failure to thrive. He was floppy and had bilateral ptosis, diminished reflexes, and poor suck. He had aspiration pneumonia, developed seizures, and died at age 3 1/2 months. Laboratory data showed lactic acidosis, proteinuria, glycosuria and generalized aminoaciduria. He was an only child, and family history was negative. Muscle biopsy showed large clumps of granules positive with oxidative enzyme stains and increased lipid droplets. Ultrastructural studies showed large aggregates of mitochondria, many of which were greatly enlarged and contained disoriented or concentric whorls of cristae and paracrystalline inclusions. Cytochrome c oxidase was absent in fresh frozen sections by histochemical staining. By biochemical assay, cytochrome c oxidase (cytochrome aa3) was 6% of normal in muscle biopsy and undetectable in autopsy muscle; spectra and content of cytochromes showed lack of cytochrome aa3, decreased cytochrome b and normal cytochrome cc1. In kidney, cytochrome-c-oxidase activity was 38% of normal and spectra showed decreased cytochromes aa3 and b. The association of fatal infantile mitochondrial myopathy, lactic acidosis and renal dysfunction was previously reported by Van Biervliet et al and appears to be a distinct nosologic entity, one of the few biochemically defined mitochondrial myopathies.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007232 Infant, Newborn, Diseases Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts. Neonatal Diseases,Disease, Neonatal,Diseases, Neonatal,Neonatal Disease
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D008297 Male Males
D008931 Mitochondria, Muscle Mitochondria of skeletal and smooth muscle. It does not include myocardial mitochondria for which MITOCHONDRIA, HEART is available. Sarcosomes,Mitochondrion, Muscle,Muscle Mitochondria,Muscle Mitochondrion,Sarcosome
D009132 Muscles Contractile tissue that produces movement in animals. Muscle Tissue,Muscle,Muscle Tissues,Tissue, Muscle,Tissues, Muscle
D009135 Muscular Diseases Acquired, familial, and congenital disorders of SKELETAL MUSCLE and SMOOTH MUSCLE. Muscle Disorders,Myopathies,Myopathic Conditions,Muscle Disorder,Muscular Disease,Myopathic Condition,Myopathy
D009245 NADH Dehydrogenase A flavoprotein and iron sulfur-containing oxidoreductase that catalyzes the oxidation of NADH to NAD. In eukaryotes the enzyme can be found as a component of mitochondrial electron transport complex I. Under experimental conditions the enzyme can use CYTOCHROME C GROUP as the reducing cofactor. The enzyme was formerly listed as EC 1.6.2.1. NADH Cytochrome c Reductase,Diaphorase (NADH Dehydrogenase),NADH (Acceptor) Oxidoreductase,NADH Cytochrome c Oxidoreductase,Dehydrogenase, NADH
D002334 Carnitine O-Palmitoyltransferase An enzyme that catalyzes reversibly the conversion of palmitoyl-CoA to palmitoylcarnitine in the inner mitochondrial membrane. EC 2.3.1.21. Carnitine Palmitoyltransferase,CPT II,Carnitine Acyltransferase I,Carnitine Palmitoyltransferase I,Carnitine Palmitoyltransferase II,Palmitoylcarnitine Transferase,Palmitylcarnitine Acyltransferase,Acyltransferase I, Carnitine,Acyltransferase, Palmitylcarnitine,Carnitine O Palmitoyltransferase,II, Carnitine Palmitoyltransferase,O-Palmitoyltransferase, Carnitine,Palmitoyltransferase I, Carnitine,Palmitoyltransferase II, Carnitine,Palmitoyltransferase, Carnitine,Transferase, Palmitoylcarnitine

Related Publications

S DiMauro, and J R Mendell, and Z Sahenk, and D Bachman, and A Scarpa, and R M Scofield, and C Reiner
January 1983, Journal of the neurological sciences,
S DiMauro, and J R Mendell, and Z Sahenk, and D Bachman, and A Scarpa, and R M Scofield, and C Reiner
January 1981, Transactions of the American Neurological Association,
S DiMauro, and J R Mendell, and Z Sahenk, and D Bachman, and A Scarpa, and R M Scofield, and C Reiner
August 1983, Annals of neurology,
S DiMauro, and J R Mendell, and Z Sahenk, and D Bachman, and A Scarpa, and R M Scofield, and C Reiner
April 1985, Annals of neurology,
S DiMauro, and J R Mendell, and Z Sahenk, and D Bachman, and A Scarpa, and R M Scofield, and C Reiner
November 1986, Archives of neurology,
S DiMauro, and J R Mendell, and Z Sahenk, and D Bachman, and A Scarpa, and R M Scofield, and C Reiner
November 1989, No to hattatsu = Brain and development,
S DiMauro, and J R Mendell, and Z Sahenk, and D Bachman, and A Scarpa, and R M Scofield, and C Reiner
June 1986, Biochemical and biophysical research communications,
S DiMauro, and J R Mendell, and Z Sahenk, and D Bachman, and A Scarpa, and R M Scofield, and C Reiner
September 1996, No to hattatsu = Brain and development,
S DiMauro, and J R Mendell, and Z Sahenk, and D Bachman, and A Scarpa, and R M Scofield, and C Reiner
August 1992, Archives of disease in childhood,
S DiMauro, and J R Mendell, and Z Sahenk, and D Bachman, and A Scarpa, and R M Scofield, and C Reiner
January 1996, Brain & development,
Copied contents to your clipboard!